Related Experiment Video
Updated: Dec 18, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Mitochondria-Targeting Organic Nanoparticles for Enhanced Photodynamic/Photothermal Therapy
Chaonan Li1,2, Wei Zhang1, Shi Liu1
1State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
Abstract:
Organelle-targeting techniques have been proved to be promising approaches for enhanced cancer treatment, especially phototherapy, because it can greatly improve the efficiency of photosensitizers. In this work, we designed and synthesized a mitochondria-targeting diketopyrrolopyrrole-based photosensitizer (DPP2+) for synergistic photodynamic/photothermal therapy upon irradiation. The obtained mitochondria-targeting nanoparticles (DPP2+ NPs) could produce thermal energy and singlet oxygen under 635 nm laser irradiation with ideal cytocompatibility. Importantly, DPP2+ NPs are more likely to enter the cells and target mitochondria. In in vitro and in vivo antitumor experiments, DPP2+ NPs showed highly effective antitumor effects, suggesting that mitochondria-targeting photosensitizers have potential for cancer treatment. The present work provides an alternative strategy to mitochondria-targeting molecular engineering and highlights the potential of organic nanomaterials in biomedical fields and cancer treatment.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...